Impact of intravenous rt-PA and additional antithrombotic agents within 24 hours on atherothrombotic large vessel occlusion requiring emergency neuroendovascular revascularization-Reference-Cited by-同舟云学术

Impact of intravenous rt-PA and additional antithrombotic agents within 24 hours on atherothrombotic large vessel occlusion requiring emergency neuroendovascular revascularization

Published:2024 Issue:1 Volume:46 Page:1-6
ISSN:0912-0726
Container-title:Japanese Journal of Stroke
language:en
Short-container-title:Jpn. J. Stroke

Author:

Miyazaki Takeshi¹,Himeno Takahiro²,Miyazaki Yuko¹,Kori Ryusuke¹,Inoue Tomoyuki²,Sato Kota²,Sato Tatsuya²,Fukushima Tomoko³,Ota Shinzo¹

Affiliation:

1. Department of Neurosurgery, Brain Attack Center Ota Memorial Hospital

2. Department of Neurology, Brain Attack Center Ota Memorial Hospital

3. Fukuyama Cerebrovascular and Medical Laboratory, Brain Attack Center Ota Memorial Hospital

Publisher

Japan Stroke Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jstroke/46/1/46_11142/_pdf

Reference14 articles.

1. 1） Yang P, Zhang Y, Zhang L, et al.: Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med 382: 1981–1993, 2020

2. 2） Zi W, Qiu Z, Li F, et al.: Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: The DEVT randomized clinical trial. JAMA 325: 234–243, 2021

3. 3） Suzuki K, Matsumaru Y, Takeuchi M, et al.: Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: The SKIP randomized clinical trial. JAMA 325: 244–253, 2021

4. 4） LeCouffe NE, Kappelhof M, Treurniet KM, et al.: A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med 385: 1833–1844, 2021

5. 5） Mitchell PJ, Yan B, Churilov L, et al.: Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet 400: 116–125, 2022